Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
101M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
17.7M
-
Shares change
-
+17.7M
-
Total reported value, excl. options
-
$401M
-
Value change
-
+$401M
-
Number of buys
-
32
-
Price
-
$22.77
Significant Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) as of Q2 2021
32 filings reported holding DAWN - Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.7M shares
of 101M outstanding shares and own 17.5% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.97M shares), FMR LLC (2.31M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.51M shares), VIKING GLOBAL INVESTORS LP (1.34M shares), JANUS HENDERSON GROUP PLC (1.3M shares), BOXER CAPITAL, LLC (1.19M shares), BVF INC/IL (919K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (819K shares), PERCEPTIVE ADVISORS LLC (756K shares), and VANGUARD GROUP INC (619K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.